Ikarovec
PrivateLast Round
Series A
Oct 22, 2025
Total Funding Raised
$10.78M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ikarovec is a biotechnology company that develops novel, multi-cistronic gene therapies for ophthalmic diseases such as age-related macular degeneration and diabetic macular edema.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ikarovec Comparables
Compare Ikarovec with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Atsena Therapeutics | 81% | |
| Beacon Therapeutics | 79% | |
| Olive Bio Therapeutics | 78% |
Ikarovec Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 22, 2025 | ||||
| Seed | Oct 23, 2024 | ||||
| Grant | Jun 15, 2020 | ||||
| Seed | Feb 5, 2020 |
Ikarovec Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| GenScript | Grant |
| UK Innovation & Science Seed Fund | Seed |
| LifeArc Ventures | Seed |
| LifeArc | Seed |
| Innovate UK | Grant |
| Parkwalk Advisors | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 72% MoM, from 1.1K to 1.9K.
- Jan 6, 2026
Developing IKAR-003 with VectorBuilder Inc. for disease progression prevention.
Ikarovec Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ikarovec's valuation, stock price, and market status.
Is Ikarovec a public or private company?
Ikarovec is a private company.
What is the current stock price of Ikarovec?
Ikarovec is a private company with no public stock price. No recent secondary market data is available.
How much is Ikarovec worth (valuation)?
Valuation information for Ikarovec is not publicly available.
Can I buy Ikarovec stock?
Ikarovec shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ikarovec's last funding round?
Ikarovec's most recent funding round was Series A on October 22, 2025.
Who are the main investors in Ikarovec?
Key investors in Ikarovec include UK Innovation & Science Seed Fund, LifeArc Ventures, LifeArc, Parkwalk Advisors.
Will Ikarovec IPO soon?
No public IPO plans have been announced for Ikarovec.
How can I track Ikarovec secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ikarovec's secondary market activity and sign up for updates.